Glenn Hassan is a biotech executive, investor, and company builder with more than 20 years of experience across biotechnology, healthcare investing, investment banking, and capital markets. He has held senior leadership roles in biotechnology companies and was previously a global healthcare investor at Citadel, Leerink Capital, and Fidelity Management & Research.

Throughout his career, Glenn has focused on identifying promising biotechnology assets, building corporate and financing strategies, and helping companies translate innovative science into investable and commercially viable businesses. He has led private and public financings, strategic transactions, and an IPO on the Hong Kong Stock Exchange.